Contact hours available until 6/30/2022.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.

Faculty, Planners and Authors Conflict of Interest Disclosure:
Ann G. Jopling disclosed that she is a Speaker for Merck, Inc. and AMAG, Inc.

Otherwise, the author(s), editor, editorial board, content reviewers, and education director reported no actual or potential conflict of interest in relation to this continuing nursing education article.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
This educational activity is provided by the Society of Urologic Nurses and Associates (SUNA).

The Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

SUNA is a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556.

This article was reviewed and formatted for contact hour credit by Michele Boyd, MSN, RN, NPD-BC, SUNA Education Director.

Learning Outcome:
After completing this education activity, the learner will be able to discuss the value of screening and referral to treatment to improve quality of life and preserve functional abilities in women with urinary incontinence.

Ann G. Jopling DNP, WHNP-BC

Appearances